Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42565e1ba071b2bae3bafa6fbe1cf833 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-530569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-06166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-51019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00942 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2013-530795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00938 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-1135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-1117 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B17-1114 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-00063 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-53717 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-51104 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F13-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-537 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-511 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M27-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F13-00 |
filingDate |
2021-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da6b1a308e685e4cbef1609af4a78b18 |
publicationDate |
2022-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022211984-A1 |
titleOfInvention |
Device to Reduce and Redirect Leaks |
abstract |
The device which may be attached inside or outside the pancreas/abdomen during surgery addresses leaks of pancreatic juice or pancreatic effluent (PE) after resection by redirecting and inactivating PE. Specifically the PE enzymes (proteases) are inactivated. Redirection is through an internal biodegradable self powered self eliminating drain with increasing gradient and then targeting or inactivating the effluent with active pharmaceutical ingredients (API) such as-protease inhibitors which are contained in graduated micro-encapsulated particles (GMEPs) coated with pH and time release shells which the device locates at optimum locations in the pancreas/abdomen. Another iteration is redirecting PE by containing the device within a mesh filled with GMEP comprising protease inhibitors (antiprotease) to inactivate PE before flowing out via openings in the mesh into the abdominal cavity as an inactivated innocuous fluid. |
priorityDate |
2021-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |